Helsinn: On Sale Bar at the Supreme Court

Helsinn Healthcare v. Teva Pharma (Supreme Court docket 2018)

Helsinn’s petition for certiorari received powerful support this week from a bevy of 10 briefs amici.  The missing factor now is a connect with from the Supreme Court docket for the sights of the Solicitor Standard (CVSG) and a resulting quick from the U.S. Authorities supporting the petition.

The Patent Act bars the patenting of innovations that were “on sale” prior to to the invention’s filing day.  The query on attraction here is irrespective of whether the AIA constrained “on sale” to only contain publicly readily available facts — or alternatively do solution and private small business promotions also rely as invalidating prior art (if at any time discovered). Dilemma Presented:

No matter if, underneath the [AIA], an inventor’s sale of an creation to a third celebration that is obligated to maintain the creation private qualifies as prior art for purposes of deciding the patentability of the creation.

I formerly wrote about the petition here:

Helsinn v. Teva: On Sale Bar Publish AIA


  • Short amicus curiae of Congressman Lamar Smith. Short submitted by Robert Armitage who was a important shepherd of the AIA argues that new law removes inventor-concentrated forfeiture provisions.  17-1229 Amicus Short of Lamar Smith
  •  Amicus quick of American Mental Home Law Affiliation. Statute amended the previous law — reducing solution prior art. Final AIPLA Amicus Short Helsin v Teva 3-30-18
  • Amicus quick of Mental Home Proprietors Affiliation. Federal Circuit approach is at odds with PTO interpretation. 17-1229 Short for Amicus
  • Short amicus curiae of Pharmaceutical Research and Suppliers of The us.  Federal Circuit selection here calls into query “countless” issued patents. 17-1229_tsac_PhRMA
  • Amicus quick of Bar Affiliation of the District of Columbia. Selection will chill innovation. 17-1229 Amicus Brief–PDFA.
  • Amicus quick of The Naples Roundtable. The “Sense Of Congress” harmonization portion of the AIA must be beneficial in the interpretation.  17-1229 Short of Amicus Curiae
  • Amicus quick of The Massachusetts Biotechnology Council.  There is now too significantly uncertainty in the law. MassBio Amicus Short Apr 2 2018 Efile Final – PDFA
  • Amicus quick of Boston Patent Law Affiliation.  The case is ripe for review.  17-1229 ac The Boston Patent Law Affiliation
  • Amicus quick of The Biotechnology Innovation Group (BIO). The Federal Circuit’s “Atextual Interpretation” sends mixed messages. 17-1229 Amicus Short
  • Amicus quick of US Inventor, Inc. “The ‘little guy’ stands to bear a disproportionate and the most harmful brunt of this “on sale” bar storm.  17-1229 TSAC Short



Dennis Crouch

Shares 0

Post Author: gupta

Leave a Reply

Your email address will not be published. Required fields are marked *